The Inhibitory Adenosine Receptor at the Neuromuscular Junction and Hippocampus of the Rat: Antagonism by 1,3,8-substituted Xanthines

Overview

Journal Br J Pharmacol

Publisher Wiley

Specialty Pharmacology

Date 1990 Oct 1

PMID 2257444

Citations 31

Authors

A M Sebastiao

T W Stone

J A Ribeiro

Affiliations

Soon will be listed here.

Abstract

1. The ability of 1,3,8-substituted xanthines to antagonize the inhibitory effects of adenosine receptor agonist on the amplitude of nerve-evoked twitches of the rat phrenic-diaphragm and on the amplitude of orthodromically-evoked population spikes, recorded from the CA1 pyramidal cells of rat hippocampal slices, was investigated. 2. 1,3-Dipropyl-8-cyclopenthylxanthine (DPCPX), 1,3-dipropyl-8-(carboxymethyloxyphenyl)xanthine (XCC), 1,3-dipropyl-8-(4-[2-aminoethyl)amino)carbonylmethyloxyphenyl)x ant hine (XAC), 1,3-dipropyl-8-(2-amino-4-chlorophenyl)xanthine (PACPX), 8-phenyltheophylline (8-PT), 1,3-diethyl-8-phenylxanthine (DPX) and PD 115,199, in concentrations virtually devoid of effect on neuromuscular transmission, shifted to the right in a near parallel manner the log concentration-response curve for the inhibitory effect of 2-chloroadenosine (CADO) on nerve-evoked twitches of the phrenic-diaphragm. Linear Schild plots with slopes near to unity were obtained for all the xanthines. 3. The order of potency of the xanthines as antagonists of the effect of CADO in the phrenic-diaphragm was DPCPX (Ki = 0.54 nM) greater than XCC (Ki = 10 nM), XAC (Ki = 11 nM), PACPX (Ki = 13 nM) greater than DPX (Ki = 22 nM), 8-PT (Ki = 25 nM) greater than PD 115,199 (Ki = 57 nM). The potency of DPCPX in antagonizing the inhibitory effects of R-N6-phenylisopropyladenosine (R-PIA) and 5'-N-ethylcarboxamide adenosine (NECA) on nerve-evoked twitch response was not statistically different from its potency in antagonizing the inhibitory effect on CADO. 4. In the hippocampal slices, DPCPX, XCC and XAC, used in concentrations virtually devoid of effect on population spike amplitude, shifted to the right in a near parallel manner the log concentrationresponse curve for the inhibitory effect of CADO on the amplitude of the population spikes. The Schild plots were linear with slopes near unity. 5. The potencies of DPCPX (K, = 0.45 nM) and XAC (K, = 11 nM) in antagonizing the inhibitory adenosine receptor at the hippocampus were similar to their potencies for antagonism of the inhibitory adenosine receptor at the phrenic-diaphragm. XCC was only slightly more potent (K, = 5.4 nM) as an antagonist of the adenosine receptor in the hippocampus than in the phrenic-diaphragm. 6. The results suggest that the inhibitory adenosine receptors in the phrenic-diaphragm and in the hippocampus of the rat are similar, and that according to the antagonist potencies, these receptors belong to the A1-adenosine receptor subtype.

Citing Articles

Selective modulation of epileptic tissue by an adenosine A receptor-activating drug.

Ghosh A, Ribeiro-Rodrigues L, Ruffolo G, Alfano V, Domingos C, Rei N Br J Pharmacol. 2024; 181(24):5041-5061.

PMID: 39300608 PMC: 11578780. DOI: 10.1111/bph.17319.

Septotemporal variation in modulation of synaptic transmission, paired-pulse ratio and frequency facilitation/depression by adenosine and GABA receptors in the rat hippocampus.

A Samara M, Oikonomou G, Trompoukis G, Madarou G, Adamopoulou M, Papatheodoropoulos C Brain Neurosci Adv. 2022; 6:23982128221106315.

PMID: 35782711 PMC: 9240614. DOI: 10.1177/23982128221106315.

Cordycepin Ameliorates Synaptic Dysfunction and Dendrite Morphology Damage of Hippocampal CA1 A1R in Cerebral Ischemia.

Chen Z, Han Y, Shang Y, Zhuang S, Huang J, Wu B Front Cell Neurosci. 2022; 15:783478.

PMID: 35002628 PMC: 8740211. DOI: 10.3389/fncel.2021.783478.

Activation of neuronal adenosine A1 receptors causes hypothermia through central and peripheral mechanisms.

Province H, Xiao C, Mogul A, Sahoo A, Jacobson K, Pinol R PLoS One. 2020; 15(12):e0243986.

PMID: 33326493 PMC: 7743955. DOI: 10.1371/journal.pone.0243986.

Novel Players in the Aging Synapse: Impact on Cognition.

Temido-Ferreira M, Coelho J, Pousinha P, Lopes L J Caffeine Adenosine Res. 2019; 9(3):104-127.

PMID: 31559391 PMC: 6761599. DOI: 10.1089/caff.2019.0013.

References

Paton W, WAUD D . The margin of safety of neuromuscular transmission. J Physiol. 1967; 191(1):59-90. PMC: 1365439. DOI: 10.1113/jphysiol.1967.sp008237. View

ARUNLAKSHANA O, SCHILD H . Some quantitative uses of drug antagonists. Br J Pharmacol Chemother. 1959; 14(1):48-58. PMC: 1481829. DOI: 10.1111/j.1476-5381.1959.tb00928.x. View

Ribeiro J, Walker J . The effects of adenosine triphosphate and adenosine diphosphate on transmission at the rat and frog neuromuscular junctions. Br J Pharmacol. 1975; 54(2):213-8. PMC: 1666647. DOI: 10.1111/j.1476-5381.1975.tb06931.x. View

van Calker D, Muller M, Hamprecht B . Adenosine regulates via two different types of receptors, the accumulation of cyclic AMP in cultured brain cells. J Neurochem. 1979; 33(5):999-1005. DOI: 10.1111/j.1471-4159.1979.tb05236.x. View

Londos C, Cooper D, Wolff J . Subclasses of external adenosine receptors. Proc Natl Acad Sci U S A. 1980; 77(5):2551-4. PMC: 349439. DOI: 10.1073/pnas.77.5.2551. View

Dunwiddie T, Fredholm B . Adenosine receptors mediating inhibitory electrophysiological responses in rat hippocampus are different from receptors mediating cyclic AMP accumulation. Naunyn Schmiedebergs Arch Pharmacol. 1984; 326(4):294-301. DOI: 10.1007/BF00501433. View

Ribeiro J, Sebastiao A . On the type of receptor involved in the inhibitory action of adenosine at the neuromuscular junction. Br J Pharmacol. 1985; 84(4):911-8. PMC: 1987060. DOI: 10.1111/j.1476-5381.1985.tb17385.x. View

Ukena D, Daly J, Kirk K, Jacobson K . Functionalized congeners of 1,3-dipropyl-8-phenylxanthine: potent antagonists for adenosine receptors that modulate membrane adenylate cyclase in pheochromocytoma cells, platelets and fat cells. Life Sci. 1986; 38(9):797-807. PMC: 4364026. DOI: 10.1016/0024-3205(86)90596-5. View

Ribeiro J, Sebastiao A . Adenosine receptors and calcium: basis for proposing a third (A3) adenosine receptor. Prog Neurobiol. 1986; 26(3):179-209. DOI: 10.1016/0301-0082(86)90015-8. View

10.

Singh Y, Dryden W, Chen H . The inhibitory effects of some adenosine analogues on transmitter release at the mammalian neuromuscular junction. Can J Physiol Pharmacol. 1986; 64(11):1446-50. DOI: 10.1139/y86-245. View

11.

Ukena D, Jacobson K, Padgett W, Ayala C, Shamim M, Kirk K . Species differences in structure-activity relationships of adenosine agonists and xanthine antagonists at brain A1 adenosine receptors. FEBS Lett. 1986; 209(1):122-8. PMC: 3469266. DOI: 10.1016/0014-5793(86)81096-1. View

12.

Martinson E, Johnson R, Wells J . Potent adenosine receptor antagonists that are selective for the A1 receptor subtype. Mol Pharmacol. 1987; 31(3):247-52. View

13.

Bruns R, Fergus J, Badger E, Bristol J, Santay L, Hartman J . Binding of the A1-selective adenosine antagonist 8-cyclopentyl-1,3-dipropylxanthine to rat brain membranes. Naunyn Schmiedebergs Arch Pharmacol. 1987; 335(1):59-63. DOI: 10.1007/BF00165037. View

14.

Fredholm B, Lindgren E . Effects of N-ethylmaleimide and forskolin on noradrenaline release from rat hippocampal slices. Evidence that prejunctional adenosine and alpha-receptors are linked to N-proteins but not to adenylate cyclase. Acta Physiol Scand. 1987; 130(1):95-105. DOI: 10.1111/j.1748-1716.1987.tb08116.x. View

15.

Lohse M, Klotz K, Reddington M, Schwabe U, Olsson R . 8-Cyclopentyl-1,3-dipropylxanthine (DPCPX)--a selective high affinity antagonist radioligand for A1 adenosine receptors. Naunyn Schmiedebergs Arch Pharmacol. 1987; 336(2):204-10. DOI: 10.1007/BF00165806. View

16.

Sebastiao A, Ribeiro J . On the adenosine receptor and adenosine inactivation at the rat diaphragm neuromuscular junction. Br J Pharmacol. 1988; 94(1):109-20. PMC: 1853929. DOI: 10.1111/j.1476-5381.1988.tb11505.x. View

17.

Bartrup J, Stone T . Presynaptic actions of adenosine are magnesium-dependent. Neuropharmacology. 1988; 27(7):761-3. DOI: 10.1016/0028-3908(88)90087-1. View

18.

Bartrup J, Stone T . Interactions of adenosine and magnesium on rat hippocampal slices. Brain Res. 1988; 463(2):374-9. DOI: 10.1016/0006-8993(88)90413-1. View

19.

Sebastiao A, Ribeiro J . 1,3,8- and 1,3,7-substituted xanthines: relative potency as adenosine receptor antagonists at the frog neuromuscular junction. Br J Pharmacol. 1989; 96(1):211-9. PMC: 1854313. DOI: 10.1111/j.1476-5381.1989.tb11802.x. View

20.

Elliott G, Lauwen A, Bonta I . Prostaglandin E2 inhibits and indomethacin and aspirin enhance, A23187-stimulated leukotriene B4 synthesis by rat peritoneal macrophages. Br J Pharmacol. 1989; 96(2):265-70. PMC: 1854358. DOI: 10.1111/j.1476-5381.1989.tb11812.x. View